TSP Capital Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Hold |
0
| – | – | – | 41 |
|
|
2025
Q4 | – | Sell |
-17,175
| Closed | -$826K | – | 42 |
|
|
2025
Q3 | $775K | Buy |
+17,175
| New | +$802K | 0.21% | 40 |
|
|
2025
Q2 | – | Sell |
-17,575
| Closed | -$863K | – | 37 |
|
|
2025
Q1 | $1.07M | Sell |
17,575
-3,167
| -15% | -$185K | 0.35% | 38 |
|
|
2024
Q4 | $1.17M | Sell |
20,742
-850
| -4% | -$47.5K | 0.4% | 38 |
|
|
2024
Q3 | $1.12M | Hold |
21,592
| – | – | 0.35% | 38 |
|
|
2024
Q2 | $897K | Sell |
21,592
-6,958
| -24% | -$311K | 0.28% | 40 |
|
|
2024
Q1 | $1.55M | Sell |
28,550
-242
| -0.8% | -$12.3K | 0.5% | 35 |
|
|
2023
Q4 | $1.48M | Sell |
28,792
-893
| -3% | -$46.9K | 0.51% | 34 |
|
|
2023
Q3 | $1.72M | Buy |
29,685
+5
| +0% | +$306 | 0.66% | 31 |
|
|
2023
Q2 | $1.9M | Sell |
29,680
-244
| -0.8% | -$16.4K | 0.68% | 32 |
|
|
2023
Q1 | $2.07M | Buy |
29,924
+4
| +0% | +$282 | 0.75% | 32 |
|
|
2022
Q4 | $2.15M | Buy |
+29,920
| New | +$2.26M | 0.81% | 31 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 30 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 29 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 29 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 32 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 33 |
|
|
2021
Q2 | – | Sell |
-33,993
| Closed | -$2.22M | – | 31 |
|
|
2021
Q1 | $2.15M | Hold |
33,993
| – | – | 0.76% | 30 |
|
|
2020
Q4 | $2.11M | Buy |
+33,993
| New | +$2.09M | 0.75% | 26 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 26 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 28 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 25 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 26 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 25 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 27 |
|
|
2019
Q1 | – | Sell |
-47,232
| Closed | -$2.35M | – | 27 |
|
|
2018
Q4 | $2.46M | Buy |
+47,232
| New | +$2.54M | 1.38% | 27 |
|
|
2018
Q3 | – | Sell |
-54,882
| Closed | -$3.26M | – | 22 |
|
|
2018
Q2 | $3.04M | Sell |
54,882
-1,500
| -3% | -$81K | 1.56% | 25 |
|
|
2018
Q1 | $3.57M | Sell |
56,382
-400
| -0.7% | -$25.7K | 1.7% | 25 |
|
|
2017
Q4 | $3.48M | Sell |
56,782
-1,050
| -2% | -$65.7K | 1.58% | 24 |
|
|
2017
Q3 | $3.69M | Buy |
+57,832
| New | +$3.38M | 1.76% | 23 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 23 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 24 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 19 |
|
|
2016
Q3 | – | Sell |
-64,435
| Closed | -$4.14M | – | 20 |
|
|
2016
Q2 | $4.74M | Sell |
64,435
-1,450
| -2% | -$102K | 2.45% | 16 |
|
|
2016
Q1 | $4.21M | Sell |
65,885
-6,967
| -10% | -$439K | 2.31% | 18 |
|
|
2015
Q4 | $5.01M | Sell |
72,852
-700
| -1% | -$46.3K | 2.68% | 15 |
|
|
2015
Q3 | $4.35M | Sell |
73,552
-3,350
| -4% | -$213K | 2.44% | 18 |
|
|
2015
Q2 | $5.12M | Buy |
+76,902
| New | +$5.07M | 2.38% | 17 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 17 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 18 |
|
|
2014
Q3 | – | Sell |
-91,565
| Closed | -$4.57M | – | 21 |
|
|
2014
Q2 | $4.44M | Buy |
+91,565
| New | +$4.51M | 1.93% | 21 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 19 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 18 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 15 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 17 |
|
Other funds holding BMY
VCM
VPM
TSP Capital Management Group's BMY Position: Q1 2026 in Review
TSP Capital Management Group held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 0 shares worth $738K. The position accounts for 0.18% of the portfolio, ranked #41.
TSP Capital Management Group first reported a position in BMY in Q2 2014 and has held it in 24 quarters since. The position peaked at $5.12M in Q2 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- TSP Capital Management Group held 0 shares of Bristol-Myers Squibb worth $738K as of Q1 2026.
- TSP Capital Management Group left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.18% of TSP Capital Management Group's portfolio in Q1 2026, its #41 holding.
- TSP Capital Management Group first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 24 quarters since.
- TSP Capital Management Group's Bristol-Myers Squibb position peaked at $5.12M in Q2 2015.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on TSP Capital Management Group's 13F filing for Q1 2026, filed 24 Apr 2026.